This is a retrospective observational cohort study. The clinical, pathological and treatment data of participants identified with adrenocortical carcinoma from the year 2000 onwards will be evaluated. Participants recruited for this study will be identified at the participating sites.
Adrenocortical carcinoma is one of the rarest neoplasms in the world. In Brazil, especially in the South and Southeast regions, the incidence of adrenocortical tumors is around 15 times higher than in the rest of the world, largely attributed to the significant prevalence of the TP53-R337H germline mutation in this population. In view of this characteristic, the clinical and epidemiological characterization of this cohort, as well as the identification of prognostic factors, is of great importance. The starting point for this project was the cohort of 66 participants with adrenal carcinoma included in the final project of the medical residency in clinical oncology at the A.C. Camargo Cancer Center by student Rafael Haikal dos Santos Abduch. The aim is to include case studies from the main Brazilian site that have followed up and treated patients with adrenal carcinoma.
Study Type
OBSERVATIONAL
Enrollment
150
Pronutrir - Suporte Nutricional e Quimioterapia
Fortaleza, Ceará, Brazil
RECRUITINGHospital do Câncer do Maranhão Dr. Tarquínio Lopes Filho
São Luís, Maranhão, Brazil
RECRUITINGDemographic Characterization of Adrenocortical Carcinoma in Brazil
This measure aims to capture essential demographic attributes of individuals in Brazil diagnosed with adrenocortical carcinoma. It will include details such as age distribution in years, gender representation, geographic distribution, height in meters, weight in kilograms, as well as racial and ethnic demographics . These insights will contribute to a comprehensive understanding of the demographic landscape of adrenocortical carcinoma within the Brazilian population.
Time frame: Throughout the study period, an average of 18 months.
Clinical Characterization of Adrenocortical Carcinoma in Brazil
This measure aims to capture essential clinical attributes of individuals in Brazil diagnosed with adrenocortical carcinoma. It will include relevant clinical factors such as tumor stage, hormone secretion status, and treatment modalities. These insights will contribute to a comprehensive understanding of the clinical landscape of adrenocortical carcinoma within the Brazilian population.
Time frame: Throughout the study period, an average of 18 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital Erasto Gaertner
Curitiba, Paraná, Brazil
RECRUITINGHospital Santa Joana Recife (Instituto Américas PE)
Recife, Pernambuco, Brazil
RECRUITINGUOPECCAN - Hospital do Câncer de Cascavel
Cascavel, Santa Catarina, Brazil
RECRUITINGFUNFARME - Hospital de Base de São José do Rio Preto
São José do Rio Preto, São Paulo, Brazil
RECRUITINGINCA - Instituto Nacional de Câncer
Rio de Janeiro, Brazil
RECRUITINGBP - A Beneficência Portuguesa de São Paulo
São Paulo, Brazil
RECRUITINGHAOC - Hospital Alemão Oswaldo Cruz
São Paulo, Brazil
RECRUITINGA.C. Camargo Cancer Center
São Paulo, Brazil
RECRUITING